Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Total Current Liabilities
Adaptive Biotechnologies Corp
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Total Current Liabilities
$83m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Current Liabilities
$14B
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
|
Danaher Corp
NYSE:DHR
|
Total Current Liabilities
$7.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Current Liabilities
$1.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
Agilent Technologies Inc
NYSE:A
|
Total Current Liabilities
$1.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
0%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Current Liabilities
$6.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
See Also
What is Adaptive Biotechnologies Corp's Total Current Liabilities?
Total Current Liabilities
83m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Total Current Liabilities amounts to 83m USD.
What is Adaptive Biotechnologies Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
6%
Over the last year, the Total Current Liabilities growth was -8%. The average annual Total Current Liabilities growth rates for Adaptive Biotechnologies Corp have been -8% over the past three years , 6% over the past five years .